TREA

97861879 - BPG BIO

Follow

Information

  • Trademark
  • 97861879
  • Serial Number
    97861879
  • Filing Date
    March 28, 2023
    2 years ago
  • Transaction Date
    April 11, 2025
    a month ago
  • Status Date
    April 09, 2025
    a month ago
  • Published for Opposition Date
    February 13, 2024
    a year ago
  • Location Date
    November 20, 2024
    5 months ago
  • Status Code
    731
  • Employee Name
    GALLOWAY, JAMILLA
  • Attorney Docket Number
    119992-91801
    Attorney Name
    Lori J. Shyavitz, Esq.
    Law Office Assigned Location Code
    N30
  • Owners
Information
Mark Drawing Code
3
Mark Identification
BPG BIO
Case File Statements
  • DM0000: The mark consists of the letters "BPG" in uppercase stylized font, a square above the top left corner of the letter "B" in "BPG", and the word "BIO" in lowercase stylized font in superscript after the letter "G".
  • GS0091: Downloadable computer software for compiling and analyzing scientific and medical data; Recorded computer software for compiling and analyzing scientific and medical data; Downloadable computer software for big data analytics, and for collecting and analyzing data in the field of healthcare; Recorded computer software for big data analytics, and for collecting and analyzing data in the field of healthcare; Downloadable computer software for use in accessing and importing data and information to analyze, visualize, share, and perform calculations within computational and analytical data models, computational algorithms, and software applications; Recorded computer software for use in accessing and importing data and information to analyze, visualize, share, and perform calculations within computational and analytical data models, computational algorithms, and software applications
  • GS0051: Pharmaceutical preparations for use in the diagnosis, prevention, management and treatment of metabolic, viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, opthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions, diseases and disorders; Diagnostic preparations for medical and veterinary use; Pharmaceutical preparations for wounds; Clinical medical reagents; Diagnostic kits comprised of medical reagents for medical and clinical use in disease testing, bodily fluid testing, biometric testing, cardiovascular testing, heart rate testing, organ function testing, hydration testing, and nutrition testing
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0441: Providing medical information in the field of medicine and pharmaceuticals; Medical services; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer research; Medical diagnostic, prognostic and theranostic screening and testing; Theranostic assessment of a disease or condition for medical purposes; Theranostic analysis services for medical purposes; Medical diagnostic and theranostic monitoring and reporting services; Health care services, namely, providing a database of diseases and the collection of disease data and information all for treatment and diagnostic purposes; Health care services, namely, providing a database in the field of patient diagnostic, admissions, discharge, transfer (ADT), electronic health records (EHR), molecular, biomarker, genomic medicine, and clinical data including medication and laboratory values with systems for output of customized knowledge and information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Patient outcome analysis services, namely, providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses, treatments and therapies associated with a defined set of symptoms and evaluating patient records, disease markers and environmental factors to provide patients with information about possible diagnoses, treatments and therapies; Predictive modeling of data in the fields of medicine and healthcare, for medical diagnostic, prognostic and treatment purposes; Providing health information; Medical information; Providing health information, medical information, disease management information, and information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, said information provided to others
  • DS0000: "BIO"
  • GS0421: Pharmaceutical, scientific, medical, biopharmaceutical and biotechnology research and development; Drug discovery services; Pharmaceutical and biopharmaceutical drug development services; Providing medical and scientific research information in the field of medicine and pharmaceuticals; Medical research services in the field of cancer; Medical testing for scientific research purposes in the field of metabolic condition and disease, cancer, biomarkers, endocrinology diseases, central nervous system diseases and inflammatory disorders; Medical research featuring the identification and validation of disease related biomarkers; Data mining; Research and development in the field of biomarkers; Research and development in the fields of biomarker discovery and validation; Medical and scientific research in the field of biomarker discovery in cancer patients; Providing scientific information in the field of pharmaceuticals; Pharmaceutical and medical research in the field of outcomes research; Medical research featuring the identification and validation of disease related biomarkers for use in improved patient outcomes; Providing on-line, non-downloadable software applications to compile and analyze scientific and medical data; Software as a service (SAAS) services featuring software for big data analytics, and for collecting and analyzing data in the field of healthcare; Providing on-line, non-downloadable computer software for use in accessing and importing scientific and medical data and information to analyze, visualize, share, and perform calculations within computational and analytical data models, computational algorithms, and software applications; Platform as a service (PAAS) featuring computer software platforms for data collection, data analytics, data storage and data mining, for use in the field of healthcare
Case File Event Statements
  • 3/31/2023 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/20/2023 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/21/2023 - 2 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 9/12/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/26/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/26/2023 - a year ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/26/2023 - a year ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/26/2023 - a year ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/26/2023 - a year ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/26/2023 - a year ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/9/2024 - a year ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/13/2024 - a year ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/24/2024 - a year ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/13/2024 - a year ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/8/2024 - 7 months ago
    18 - SOU EXTENSION 1 FILED Type: EXT1
  • 10/8/2024 - 7 months ago
    16 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/9/2024 - a year ago
    15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 4/9/2025 - a month ago
    21 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/9/2025 - a month ago
    22 - SOU EXTENSION 2 FILED Type: EXT2
  • 4/10/2025 - a month ago
    23 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 4/10/2025 - a month ago
    24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/20/2024 - 5 months ago
    17 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 11/20/2024 - 5 months ago
    19 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 11/20/2024 - 5 months ago
    20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA